Natalie Banner, Chief Ethics and Engagement Officer for Genomics England, shares how we can help to address the inequities in ...

Job Description Key responsibilities Working collaboratively with the Participant Panel Chair and Vice-Chair for Rare ...

Our vision is that all patients, regardless of their background, receive the same quality of genomics-enabled personalised medicine, supported by the latest research on people like them.

The Genomics England Research Network is a collaborative initiative, offering members opportunities to share and leverage expertise and resources, with the academic researchers, healthcare ...

One of the main aims of the 100,000 Genomes Project was to improve cancer care for NHS patients through personalised medicine. This page covers the way the project met this aim. Cancer can be ...

This short video explains what the Genomics England Research Environment is, how genomic data is de-identified and added to the Research Environment, and how researchers can access this de-identified ...

We're working in partnership with NHS England and the NHS Genomic Medicine Service to develop a personalised and predictive healthcare solution through the use of genomics. Genomic medicine uses ...

Our mission is to continue refining, scaling, and evolving our ability to enable others to deliver genomic healthcare and conduct genomic research.

None of our work would be possible without the consent and support of patients and participants – they are at the heart of everything that we do. By enabling scientists and clinicians in their ...

As a group of UK and international scientific experts, our Science Advisory Committee advises us on the development and delivery of Genomics England's research programmes. This committee plays a key ...

In this episode of our explainer podcasts, we’ve asked Emma McCargow, Programme Lead for the cancer programme at Genomics England, to explain in less than 10 minutes, the difference between long-read ...

Genomics England's very first initiative – sequencing 100,000 genomes from around 85,000 NHS patients affected by rare disease or cancer – is leading to groundbreaking insights and continued findings ...